GlassScriptPhysician profile
Pablo Bisono Rodriguez
NPI 1366412801
$3,042.94
in general payments reported to CMS, 2019-2025
9 companies · $25.00 in 2025
The $25.00 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,118 · 2020: $248 · 2021: $25.00 · 2022: $198 · 2023: $429 · 2025: $25.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,417.08 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $249.55 | 2019-2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $147.81 | 2019-2023 | Farxiga |
| Boston Scientific Corporation | $82.76 | 2023 | Watchman Access System |
| Pbg Puerto Rico LLC | $40.86 | 2020-2021 | |
| Pfizer INC. | $34.67 | 2019 | |
| Dexcom, INC. | $25.00 | 2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $24.24 | 2019 | |
| Seqirus USA INC | $20.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pablo Bisono Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.